Medical Therapeutics for the Treatment of Vascular Anomalies
- 21 October 2023
- journal article
- research article
- Published by Elsevier in Oral and Maxillofacial Surgery Clinics of North America
- Vol. 36 (1) , 125-136
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Rapamycin improves TIE2-mutated venous malformation in murine model and human subjectsJournal of Clinical Investigation, 2015
- Vascular Anomalies Classification: Recommendations From the International Society for the Study of Vascular AnomaliesPediatrics, 2015
- Successful Treatment of Macroglossia Due to Lymphatic Malformation With SirolimusAnnals of Otology, Rhinology & Laryngology, 2015
- Successful treatment of kaposiform lymphangiomatosis with sirolimusPediatric Blood & Cancer, 2015
- Kaposiform lymphangiomatosis: Unifying features of a heterogeneous disorderPediatric Blood & Cancer, 2014
- Bevacizumab in Patients With Hereditary Hemorrhagic Telangiectasia and Severe Hepatic Vascular Malformations and High Cardiac OutputJAMA, 2012
- Efficacy of Thalidomide for Refractory Gastrointestinal Bleeding From Vascular MalformationGastroenterology, 2011
- Sirolimus for the treatment of complicated vascular anomalies in childrenPediatric Blood & Cancer, 2011
- Oral rapamycin in the treatment of patients with hamartoma syndromes and PTEN mutationPediatric Blood & Cancer, 2011
- Thalidomide is an inhibitor of angiogenesis.Proceedings of the National Academy of Sciences, 1994